Xeris Pharmaceuticals | XERS - Interest Income


Xeris Pharmaceuticals reported $1.16M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Celltrion KRW 676.66M 6.85B Jun/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 8.53M 3.53M Sep/2025
Pharma Mar EUR 4.8M 6.4M Dec/2024
Qiagen NV USD 15.07M 1.21M Sep/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025
Tilray USD 12.83M 20.19M May/2024
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025